Half-year report · HY
4578.TEDINET S100YTLB
Period2026-01-01 → 2026-06-30
Filed2026-07-31
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.33T | 2026-01-01 → 2026-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.47T | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.18T | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥278.5bn | 2026-01-01 → 2026-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥242.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥285.4bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥468.0bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥226.3bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥215.6bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥363.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥173.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥218.5bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥175.9bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥4.40T | at 2026-06-30 | Cons. | Assets IFRS |
| Total assets | ¥4.20T | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.79T | at 2025-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.09T | at 2026-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.10T | at 2025-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.31T | at 2026-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.10T | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.79T | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.78T | at 2024-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥3.24T | at 2026-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.03T | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.72T | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥469.5bn | at 2026-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥534.6bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥411.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥426.2bn | at 2024-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥217.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥403.6bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥212.7bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥173.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥161.6bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥130.9bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥114.3bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥137.3bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥85.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥409.07 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥685.06 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥326.12 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| Equity ratio | 73.7% | at 2026-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 72.3% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.8% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥65.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥63.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥6.2bn |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥1.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥28.7bn |
| Consumer Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥17.5bn |
| Consumer Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥17.4bn |
| Consumer Productsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥15m |
| Consumer Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥13.8bn |
| Nutraceuticalsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥300.1bn |
| Nutraceuticalsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥300.1bn |
| Nutraceuticalsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| Nutraceuticalsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥36.8bn |
| Pharmaceuticalsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥951.6bn |
| Pharmaceuticalsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥951.6bn |
| Pharmaceuticalsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥250.4bn |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥1.33T |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥1.33T |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥1.8bn |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥307.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥56.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥55.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥5.0bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥27.8bn |
| Consumer Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥15.8bn |
| Consumer Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥15.8bn |
| Consumer Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥9m |
| Consumer Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥12.9bn |
| Nutraceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥276.1bn |
| Nutraceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥276.0bn |
| Nutraceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥19m |
| Nutraceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥36.7bn |
| Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥833.8bn |
| Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥833.8bn |
| Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥215.4bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥1.18T |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥1.18T |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥269.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 797
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)川 瀬 洋 人 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)渡 辺 雄 一 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)松 尾 洋 孝 | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior1InterimDuration | 1180766000000 | JPY |
| Revenue IFRS (5-year summary) | InterimDuration | 1332390000000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 2468892000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1InterimDuration | 226343000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | InterimDuration | 285420000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 468037000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1InterimDuration | 173529000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | InterimDuration | 215612000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 363150000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1InterimDuration | 90543000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | InterimDuration | 272606000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 438633000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1InterimInstant | 2722396000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | InterimInstant | 3239710000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 3033444000000 | JPY |
| Total assets IFRS (5-year summary) | Prior1InterimInstant | 3789298000000 | JPY |
| Total assets IFRS (5-year summary) | InterimInstant | 4395890000000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 4197562000000 | JPY |
| Basic earnings loss per share IFRS (5-year summary) | Prior1InterimDuration | 326.12 | |
| Basic earnings loss per share IFRS (5-year summary) | InterimDuration | 409.07 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 685.06 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings loss per share IFRS (5-year summary) | InterimDuration | － | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YearDuration | － | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1InterimInstant | 0.718 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | InterimInstant | 0.737 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1YearInstant | 0.723 | |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1InterimDuration | 212725000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | InterimDuration | 217107000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YearDuration | 403579000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1InterimDuration | -130943000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | InterimDuration | -173007000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -161585000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1InterimDuration | -85383000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | InterimDuration | -114315000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | -137344000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1InterimInstant | 411111000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | InterimInstant | 469548000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 534645000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 542988917 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 542988917 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 542988917 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 542988917 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 76394000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |